Trials / Conditions / NK/T Cell Lymphoma Nos
NK/T Cell Lymphoma Nos
5 registered clinical trials studyying NK/T Cell Lymphoma Nos — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Efficacy and Safety of BV With Tislelizumab for the Treatment of CD30+ Relapsed/Refractory NK/T-cell Lymphoma NCT05316246 | Shanghai Zhongshan Hospital | Phase 2 |
| Recruiting | A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Ant NCT04365036 | Sun Yat-sen University | Phase 3 |
| Unknown | Lenalidomide and Sintilimab for Relapsed/Refractory NK/T-cell Lymphoma NCT04231370 | Beijing Tongren Hospital | Phase 2 |
| Active Not Recruiting | Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal NCT04127227 | Sun Yat-sen University | Phase 2 |
| Unknown | Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Extra-nodal NK/T Cell Lymphoma NCT04484506 | Peking University | Phase 2 |